slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Authors PowerPoint Presentation
play fullscreen
1 / 16
Download Presentation

Authors - PowerPoint PPT Presentation

norris
124 Views
Download Presentation

Authors

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Transcatheter closure of Patent ductus arteriosus and Atrial septal defect without an onsite surgical backup; Two years experience in an African Community.”

  2. Authors • BA Animasahun, • A Johnson, • OO Ogunkunle, • OA Idowu • F Bode-Thomas • S Maheshwari, • SI Omokhodion • OF Njokanma, DR BA ANIMASAHUN

  3. Introduction • Congenital heart disease contributes significantly to the health burden of children in Nigeria. • Interventions for congenital heart disease had been available in the developed world since the first report on device closure of PDA in 1967 by Porstmann. • However this did not commence in Nigeria until October 2010. DR BA ANIMASAHUN

  4. AIM • To highlight the profiles of the patients who have undergone interventional cardiac catheterization for CHDs locally recently • The challenges encountered and the prospects associated with the procedures. DR BA ANIMASAHUN

  5. Methods • Prospective and cross sectional • Reddington Multispecialist Hospital, Lagos. • Oct 2010- Oct 2012. • They all had CHD confirmed with a baseline TTE using a Hewlett-Packard SONOS 5500 machine and transducer with a frequency of 5MHz • Ethical clearance • Social class classification • Data analyzed using Microsoft Excel program. DR BA ANIMASAHUN

  6. Results • Twelve patients were recruited into the study. • All referred, 75% from public hospital and 25% from private hospital. • The age range : 3 years to 62 years with a mean age + SD of 13.5+ 17.7 years • 25.0% M and 75.0% F with M/F of 1: 2.3 DR BA ANIMASAHUN

  7. Results contd • All had acyanotic congenital heart disease: • 73% had Patent Ductus Arteriosus (PDA) while 17% had secundum atrial septal defect (ASD). • Age range for those who had Patent ductus arteriosus was lower (3-16years with a mean age in years + SD of 6.3+ 4.22) than 34-62years for secundum ASD (48.0+ 19.8). DR BA ANIMASAHUN

  8. Table 1:Profile of patient and diagnosis DR BA ANIMASAHUN

  9. Table 1:Profile of patient and diagnosis DR BA ANIMASAHUN

  10. Table 1:Profile of patient and diagnosis DR BA ANIMASAHUN

  11. Table 2:Age at diagnosis, weight, age at device closure and device size used DR BA ANIMASAHUN

  12. Table 2:Age at diagnosis, weight, age at device closure and device size used DR BA ANIMASAHUN

  13. Table 2:Age at diagnosis, weight, age at device closure and device size used DR BA ANIMASAHUN

  14. Discussion • Number of cases • Mean age • Mode of sponsorship • Outcome of the procedure • Number of functioning cardiac cath lab • Number of Trained manpower • Consumables • Cost of the procedure DR BA ANIMASAHUN

  15. Recommendations • Establishment of more functioning cardiac catheterization labouratories • Training and re-training of manpower • Referral chain/Partnership • Local manufacturing and sale of consumables. • Collaboration DR BA ANIMASAHUN

  16. THANK YOU DR BA ANIMASAHUN